Acerca deEmpresas
AyudaPrivacidadTérminos
ResumenLegal y estadoLínea temporalRedPropiedad y gestiónAccionistasBeneficiario finalGeografíaFinanzasSalud financieraDocumentos
ResumenLegal y estadoLínea temporalRedPropiedad y gestiónAccionistasBeneficiario finalGeografíaFinanzasSalud financieraDocumentos

PERFORMANCE PHARMATECH LTD.

Private Limited Company (Ltd.)•Activa

Resumen

País🇬🇧Reino Unido
EstadoActiva
Número de registro06775451
Fundada17/12/2008
Objeto socialOther human health activities
Dirección10 Wellington Street, Cambridge, Cambridgeshire, CB1 1HW
Declaración de confirmaciónPróximo vencimiento: 30/12/2026; Última elaboración: —

Legal y estado

Forma legalPrivate Limited Company (Ltd.)
EstadoActiva
Fecha de registro17/12/2008
Autoridad registral—

Fuente: — · Última actualización: 2/12/2025

Línea temporal (32 eventos)

5/2/2026

Cuentas anuales presentadas

Micro company accounts made up to 31 December 2025

Ver archivo en Documentos

15/12/2025

Nombramiento Judith Osborne (persona)

Nombrado como Director

17/12/2008

Nombramiento Paul Michael Osborne (persona)

Nombrado como Director

Red

Este diagrama tiene muchas conexiones. para una mejor experiencia.
Press enter or space to select a node. You can then use the arrow keys to move the node around. Press delete to remove it and escape to cancel.
Press enter or space to select an edge. You can then press delete to remove it or escape to cancel.
Profundidad de la red

Propiedad y gestión

Persons with significant control

Paul Michael Osborne

25–50% shares

Nombrado el: 6/4/2016

37.5%
Paul Michael Osborne

25–50% shares

Nombrado el: 6/4/2016

37.5%
Judith Osborne

25–50% shares

Nombrado el: 6/4/2016

37.5%
Judith Osborne

25–50% shares

Nombrado el: 6/4/2016 · Dimitió el: 14/12/2025

37.5%

Officers & directors

Judith Osborne

Director

Nombrado el: 15/12/2025

—

Mostrando 1–5 de 8

1 / 2

Línea temporal de propiedad (4 cambios)

15/12/2025

Nombramiento Judith Osborne (persona)

Persona con control significativo

14/12/2025

Baja Judith Osborne (persona)

Persona con control significativo

6/4/2016

Nombramiento Paul Michael Osborne (persona)

Persona con control significativo

Accionistas

NombreParticipaciónVotoDesde
▓▓▓▓▓▓▓▓▓▓▓▓
█.██%
██%
█.█%
▓▓▓▓▓▓▓▓▓▓▓
██%
█.█%
██.██%
▓▓▓▓▓▓▓▓▓▓▓▓▓
█.█%
██.██%
██.█%
▓▓▓▓▓▓▓▓▓▓
██.██%
██.█%
█.██%
▓▓▓▓▓▓▓▓▓▓▓▓
██.█%
█.██%
██%
▓▓▓▓▓▓▓▓▓▓▓
█.██%
██%
█.█%
▓▓▓▓▓▓▓▓▓▓▓▓▓
██%
█.█%
██.██%
▓▓▓▓▓▓▓▓▓▓
█.█%
██.██%
██.█%

Beneficiario final

NombreParticipaciónPaísDesde
▓▓▓▓▓▓▓▓▓▓▓▓
█.██%
██%
█.█%
▓▓▓▓▓▓▓▓▓▓▓
██%
█.█%
██.██%
▓▓▓▓▓▓▓▓▓▓▓▓▓
█.█%
██.██%
██.█%
▓▓▓▓▓▓▓▓▓▓
██.██%
██.█%
█.██%
▓▓▓▓▓▓▓▓▓▓▓▓
██.█%
█.██%
██%
▓▓▓▓▓▓▓▓▓▓▓
█.██%
██%
█.█%
▓▓▓▓▓▓▓▓▓▓▓▓▓
██%
█.█%
██.██%
▓▓▓▓▓▓▓▓▓▓
█.█%
██.██%
██.█%

Geografía

Sede

10 Wellington Street

Cambridge

Cambridgeshire

CB1 1HW

Finanzas

Cifras clave de cuentas anuales.

Convertir a

2013

Beneficio / (pérdida): £56.5K

Cifras clave

Beneficio / (pérdida)

2013£56.477
2014£102.148
2015£230.332
2016—
2017—
2018—
2019—
2020—
2021—
2022—
2023—
2024—

Activo total

2013£56.479
2014£102.150
2015£230.334
2016£371.205
2017£486.498
2018£319.822
2019£322.320
2020£218.810
2021£212.958
2022£239.537
2023£118.827
2024£85.470

Net Assets Liabilities

2013—
2014—
2015—
2016£371.205
2017£486.498
2018£319.822
2019£322.320
2020£218.810
2021£212.958
2022£239.537
2023£118.827
2024£85.470

Equity

2013—
2014—
2015—
2016£371.205
2017£486.498
2018£319.822
2019£322.320
2020£218.810
2021£212.958
2022£239.537
2023£118.827
2024£85.470

Current Assets

2013£72.631
2014£137.618
2015£292.050
2016£418.708
2017£586.167
2018£343.787
2019£381.992
2020£226.016
2021£227.038
2022£265.063
2023£124.656
2024£94.000

Net Current Assets Liabilities

2013£55.273
2014£99.556
2015£224.338
2016£364.941
2017£495.531
2018£316.390
2019£320.880
2020£218.412
2021£212.272
2022£239.579
2023£118.709
2024£85.192

Total Assets Less Current Liabilities

2013—
2014—
2015—
2016£371.906
2017£502.807
2018£320.397
2019£322.895
2020£219.385
2021£213.533
2022£240.112
2023£119.402
2024£86.327

Debtors

2013£28.594
2014£56.721
2015£119.644
2016—
2017—
2018—
2019—
2020—
2021—
2022—
2023—
2024—

Creditors

2013—
2014—
2015—
2016£54.740
2017£91.480
2018£29.313
2019£62.070
2020£8298
2021£15.387
2022£26.012
2023£6676
2024£9221

Number Shares Allotted

20132
20142
20152
2016—
2017—
2018—
2019—
2020—
2021—
2022—
2023—
2024—

Par Value Share

2013£1
2014£1
2015£1
2016—
2017—
2018—
2019—
2020—
2021—
2022—
2023—
2024—

Average Number Employees During Period

2013—
2014—
2015—
2016—
2017—
2018—
2019—
20202
20212
20222
20232
20242

Accrued Liabilities Not Expressed Within Creditors Subtotal

2013—
2014—
2015—
2016£701
2017£16.309
2018£575
2019£575
2020£575
2021£575
2022£575
2023£575
2024£857

Called Up Share Capital

2013£2
2014£2
2015£2
2016—
2017—
2018—
2019—
2020—
2021—
2022—
2023—
2024—

Capital Employed

2013£56.479
2014£102.150
2015£230.334
2016—
2017—
2018—
2019—
2020—
2021—
2022—
2023—
2024—

Cash Bank In Hand

2013£44.037
2014£40.897
2015£72.406
2016—
2017—
2018—
2019—
2020—
2021—
2022—
2023—
2024—

Creditors Due Within One Year

2013£17.358
2014£38.062
2015£67.712
2016—
2017—
2018—
2019—
2020—
2021—
2022—
2023—
2024—

Current Asset Investments

2013£40.000
2014£40.000
2015£100.000
2016—
2017—
2018—
2019—
2020—
2021—
2022—
2023—
2024—

Fixed Assets

2013—
2014—
2015—
2016£6965
2017£7276
2018£4007
2019£2015
2020£973
2021£1261
2022£533
2023£693
2024£1135

Net Assets Liabilities Including Pension Asset Liability

2013£56.479
2014£102.150
2015£230.334
2016—
2017—
2018—
2019—
2020—
2021—
2022—
2023—
2024—

Prepayments Accrued Income Not Expressed Within Current Asset Subtotal

2013—
2014—
2015—
2016£973
2017£844
2018£1916
2019£958
2020£694
2021£621
2022£528
2023£729
2024£413

Profit Loss Account Reserve

2013£56.477
2014£102.148
2015£230.332
2016—
2017—
2018—
2019—
2020—
2021—
2022—
2023—
2024—

Share Capital Allotted Called Up Paid

2013£2
2014£2
2015£2
2016—
2017—
2018—
2019—
2020—
2021—
2022—
2023—
2024—

Tangible Fixed Assets

2013£1206
2014£2594
2015£5996
2016—
2017—
2018—
2019—
2020—
2021—
2022—
2023—
2024—

Tangible Fixed Assets Additions

2013£3206
2014£6922
2015£6132
2016—
2017—
2018—
2019—
2020—
2021—
2022—
2023—
2024—

Tangible Fixed Assets Cost Or Valuation

2013£5953
2014£11.308
2015£16.406
2016—
2017—
2018—
2019—
2020—
2021—
2022—
2023—
2024—

Tangible Fixed Assets Depreciation

2013£3359
2014£5312
2015£9441
2016—
2017—
2018—
2019—
2020—
2021—
2022—
2023—
2024—

Tangible Fixed Assets Depreciation Charged In Period

2013£1818
2014£3178
2015£5163
2016—
2017—
2018—
2019—
2020—
2021—
2022—
2023—
2024—

Tangible Fixed Assets Depreciation Decrease Increase On Disposals

2013£966
2014£1225
2015£1034
2016—
2017—
2018—
2019—
2020—
2021—
2022—
2023—
2024—

Tangible Fixed Assets Disposals

2013£966
2014£1567
2015£1034
2016—
2017—
2018—
2019—
2020—
2021—
2022—
2023—
2024—
Métrica201320142015201620172018201920202021202220232024
Beneficio / (pérdida)£56.477£102.148£230.332—————————
Activo total£56.479£102.150£230.334£371.205£486.498£319.822£322.320£218.810£212.958£239.537£118.827£85.470
Net Assets Liabilities———£371.205£486.498£319.822£322.320£218.810£212.958£239.537£118.827£85.470
Equity———£371.205£486.498£319.822£322.320£218.810£212.958£239.537£118.827£85.470
Current Assets£72.631£137.618£292.050£418.708£586.167£343.787£381.992£226.016£227.038£265.063£124.656£94.000
Net Current Assets Liabilities£55.273£99.556£224.338£364.941£495.531£316.390£320.880£218.412£212.272£239.579£118.709£85.192
Total Assets Less Current Liabilities———£371.906£502.807£320.397£322.895£219.385£213.533£240.112£119.402£86.327
Debtors£28.594£56.721£119.644—————————
Creditors———£54.740£91.480£29.313£62.070£8298£15.387£26.012£6676£9221
Number Shares Allotted222—————————
Par Value Share£1£1£1—————————
Average Number Employees During Period———————22222
Accrued Liabilities Not Expressed Within Creditors Subtotal———£701£16.309£575£575£575£575£575£575£857
Called Up Share Capital£2£2£2—————————
Capital Employed£56.479£102.150£230.334—————————
Cash Bank In Hand£44.037£40.897£72.406—————————
Creditors Due Within One Year£17.358£38.062£67.712—————————
Current Asset Investments£40.000£40.000£100.000—————————
Fixed Assets———£6965£7276£4007£2015£973£1261£533£693£1135
Net Assets Liabilities Including Pension Asset Liability£56.479£102.150£230.334—————————
Prepayments Accrued Income Not Expressed Within Current Asset Subtotal———£973£844£1916£958£694£621£528£729£413
Profit Loss Account Reserve£56.477£102.148£230.332—————————
Share Capital Allotted Called Up Paid£2£2£2—————————
Tangible Fixed Assets£1206£2594£5996—————————
Tangible Fixed Assets Additions£3206£6922£6132—————————
Tangible Fixed Assets Cost Or Valuation£5953£11.308£16.406—————————
Tangible Fixed Assets Depreciation£3359£5312£9441—————————
Tangible Fixed Assets Depreciation Charged In Period£1818£3178£5163—————————
Tangible Fixed Assets Depreciation Decrease Increase On Disposals£966£1225£1034—————————
Tangible Fixed Assets Disposals£966£1567£1034—————————

Documentos

Micro company accounts made up to 31 December 2025

5/2/2026

Ver

Change of director details

2/2/2026

Ver

Change of details for person with significant control

30/1/2026

Ver

Change of director details

30/1/2026

Ver

Change of details for person with significant control

30/1/2026

Ver

IA de documentos

Próximamente

Companexia Document AI

Haga preguntas sobre presentaciones y extractos—nuestra IA leerá los documentos y responderá en contexto.

Confirmation statement

30/1/2026

Ver

Cessation as person with significant control

30/1/2026

Ver

Change of director details

30/1/2026

Ver

Termination of director appointment

30/1/2026

Ver

Mostrando 1–10 de 51

1 / 6

Explorar más empresas y personas

🇮🇪KILDALE LIMITED🇮🇪AVONMOUNT LIMITED🇮🇪KERRY FARM MACHINERY (TRALEE) LIMITEDDRESCHER, IRAKevin Nelson🇬🇧Mr David William Benbow
Ratio de liquidez corriente (2015)Ratio de liquidez corriente
4,31×
Beneficio / (pérdida) interanual (2014 vs. 2015)Beneficio / (pérdida) interanual
+125,5 %
Rentabilidad sobre activos (neta) (2015)Rentabilidad sobre activos (neta)
100 %
Ratio de fondos propios (2024)Ratio de fondos propios
100 %
Activos totales interanuales (2023 vs. 2024)Activos totales interanuales
-28,1 %

Salud financiera

Ratios derivados de las cuentas anuales. Se omiten los valores cuando faltan datos o no son significativos.

Crecimiento

Beneficio / (pérdida) interanual (2013 vs. 2014)
+80,9 %
Activos totales interanuales (2013 vs. 2014)
+80,9 %
Activo circulante neto interanual (2013 vs. 2014)
+80,1 %
Beneficio / (pérdida) interanual (2014 vs. 2015)
+125,5 %
Activos totales interanuales (2014 vs. 2015)
+125,5 %
  1. –Cambridge
  2. –PERFORMANCE PHARMATECH LTD.
Activo circulante neto interanual (2014 vs. 2015)
+125,3 %
Activos totales interanuales (2015 vs. 2016)
+61,2 %
Activo circulante neto interanual (2015 vs. 2016)
+62,7 %
Activos totales interanuales (2016 vs. 2017)
+31,1 %
Activo circulante neto interanual (2016 vs. 2017)
+35,8 %
Activos totales interanuales (2017 vs. 2018)
-34,3 %
Activo circulante neto interanual (2017 vs. 2018)
-36,2 %
Activos totales interanuales (2018 vs. 2019)
+0,8 %
Activo circulante neto interanual (2018 vs. 2019)
+1,4 %
Activos totales interanuales (2019 vs. 2020)
-32,1 %
Activo circulante neto interanual (2019 vs. 2020)
-31,9 %
Activos totales interanuales (2020 vs. 2021)
-2,7 %
Activo circulante neto interanual (2020 vs. 2021)
-2,8 %
Activos totales interanuales (2021 vs. 2022)
+12,5 %
Activo circulante neto interanual (2021 vs. 2022)
+12,9 %
Activos totales interanuales (2022 vs. 2023)
-50,4 %
Activo circulante neto interanual (2022 vs. 2023)
-50,5 %
Activos totales interanuales (2023 vs. 2024)
-28,1 %
Activo circulante neto interanual (2023 vs. 2024)
-28,2 %
CAGR activos totales (2013–2024)
+3,8 %

Eficiencia y rentabilidad

Rentabilidad sobre activos (neta) (2013)
100 %
Rentabilidad sobre activos (neta) (2014)
100 %
Rentabilidad sobre activos (neta) (2015)
100 %

Capital circulante y liquidez

Ratio de liquidez corriente (2013)
4,18×
Activo circulante neto (2013)
55.273 GBP
Ratio de liquidez corriente (2014)
3,62×
Activo circulante neto (2014)
99.556 GBP
Ratio de liquidez corriente (2015)
4,31×
Activo circulante neto (2015)
224.338 GBP
Activo circulante neto (2016)
364.941 GBP
Activo circulante neto (2017)
495.531 GBP
Activo circulante neto (2018)
316.390 GBP
Activo circulante neto (2019)
320.880 GBP
Activo circulante neto (2020)
218.412 GBP
Activo circulante neto (2021)
212.272 GBP
Activo circulante neto (2022)
239.579 GBP
Activo circulante neto (2023)
118.709 GBP
Activo circulante neto (2024)
85.192 GBP

Estructura de capital

Ratio de fondos propios (2016)
100 %
Ratio de fondos propios (2017)
100 %
Ratio de fondos propios (2018)
100 %
Ratio de fondos propios (2019)
100 %
Ratio de fondos propios (2020)
100 %
Ratio de fondos propios (2021)
100 %
Ratio de fondos propios (2022)
100 %
Ratio de fondos propios (2023)
100 %
Ratio de fondos propios (2024)
100 %
Inicio